A new study out of Finland, as reported on May 14, 2025, reveals that children diagnosed with ADHD are staying on medication far longer than we’ve ever had reliable data for—and yet the safety net of clinical evidence hasn’t kept pace. On average, kids in the Finnish cohort remain medicated for more than three years, and those in the top decile endure treatment for over seven years. Imagine handing someone a pair of wings without teaching them to fly—and now envision those wings strapped on for years without knowing how they affect the body. The study lead, Päivi Ruokoniemi, says, “a significant proportion of young children, especially boys, are on ADHD medication for years, throughout their comprehensive school years.” That’s not just care—that’s a long flight into the unknown. Yet, the regulatory safety net only extends to a one‑year randomized study window. After that, we’re essentially gliding blind. Boys start younger and stick around longer. The largest group—boys diagno...